Diagnostic Workup for Celiac Disease and Crohn's Disease
Celiac Disease Workup
Start with IgA tissue transglutaminase (TG2-IgA) serology as your initial test while the patient is consuming gluten 1.
Step-by-Step Algorithm:
1. Initial Serology (Patient MUST be on gluten-containing diet)
- Order IgA TG2 as the single best screening test 1
- Simultaneously check total IgA level to rule out IgA deficiency (occurs in ~2-3% of celiac patients) 1
- If IgA deficient: order IgG deamidated gliadin antibody and TG2-IgG instead 1
Critical Pitfall: Never test patients who have already started a gluten-free diet—this dramatically reduces sensitivity. If they've already eliminated gluten, have them consume 3 slices of wheat bread daily for 1-3 months before testing 1.
2. Interpretation of Serology Results
High-Positive TG2-IgA (>10x upper normal limit):
- In the most recent 2025 ESsCD guidelines, selected adults with very high TG2-IgA (≥10x ULN) may be diagnosed without biopsy 2
- However, in most adults, proceed to EGD with biopsies for differential diagnosis 1
Positive but not high-positive TG2-IgA:
- Proceed directly to EGD with duodenal biopsies 1
Negative TG2-IgA but high clinical suspicion:
- Still perform EGD with biopsies—seronegative celiac exists 1
3. Endoscopic Biopsy Protocol
- Minimum 4 biopsies from the second part of duodenum 3, 2
- 2 biopsies from duodenal bulb (at 9 o'clock and 12 o'clock positions) 3
- Take biopsies from both inflamed AND normal-appearing areas 1
4. Confirmatory Testing in Unclear Cases
- HLA-DQ2/DQ8 genetic testing has limited diagnostic value but excellent negative predictive value 1, 2
- Use primarily to rule out celiac in patients with equivocal histology or those already on gluten-free diet 1
- Absence of both DQ2 and DQ8 essentially excludes celiac disease 1
Crohn's Disease Workup
There is no single reference standard for Crohn's disease—diagnosis requires combining clinical, biochemical, endoscopic, imaging, and histological findings 4.
Step-by-Step Algorithm:
1. Initial Laboratory Assessment
- Stool studies: Rule out infectious causes (bacterial culture, C. difficile toxin, ova/parasites if travel history) 4
- Inflammatory markers: CRP, ESR
- CBC: Check for anemia, thrombocytosis
- Fecal calprotectin: Elevated suggests intestinal inflammation (though not specific for IBD)
Critical Distinction: Loose stools >6 weeks typically discriminates IBD from most infectious diarrhea 4.
2. Endoscopic Evaluation
- Ileocolonoscopy with biopsies is required for diagnosis 4
- Take biopsies from both inflamed AND uninflamed segments 4
- Exception: In acute severe colitis, sigmoidoscopy alone may suffice to avoid perforation risk 4
Key Endoscopic Features Suggesting Crohn's (though none are specific):
- Discontinuous, patchy lesions (skip lesions) 4
- Strictures and fistulae 4
- Perianal involvement 4
- Aphthous ulcers, cobblestoning
- Rectal sparing (unlike UC which typically involves rectum)
3. Cross-Sectional Imaging
- MR enterography or CT enterography to assess small bowel involvement (which colonoscopy cannot reach) 4
- Evaluate for complications: strictures, fistulae, abscesses, bowel wall thickening
4. Histopathology
- Look for: granulomas (present in only ~30% of cases), transmural inflammation, focal cryptitis
Important Limitations:
- Serologic markers (pANCA, ASCA) have limited accuracy and are not recommended for routine diagnosis 4
- Genetic testing for IBD susceptibility SNPs cannot diagnose IBD 4
Key Differences in Approach
Celiac: Serology-driven diagnosis with confirmatory biopsy in most cases; patient must be on gluten during testing
Crohn's: No serologic test available; requires direct visualization with ileocolonoscopy plus imaging to assess small bowel; diagnosis is a composite of multiple findings rather than a single test